Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AZN crawled time : 21:00 save search
MANDARA Phase III data published in New England Journal of Medicine show remission is an achievable goal in eosinophilic granulomatosis with polyangiitis (EGPA) with FASENRA
Published: 2024-02-23 (Crawled : 21:00) - biospace.com/
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.29%
H: 1.49%
C: 1.34%
show
Genprex Publishes Positive Clinical Data from Phase 1 Portion of Acclaim-1 Clinical Trial Evaluating REQORSA® Immunogene Therapy in Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting
Published: 2023-05-25 (Crawled : 21:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: -0.02%
GNPX | $2.2194 -2.31% 38K
|
Health Technology
|
| O: 3.65%
H: 7.04%
C: 1.02%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.06%
H: 0.48%
C: -0.04%
reqorsa lung asco positive cancer cell meeting trial therapy
Over-The-Counter Drug Market size to grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories and Achelios Therapeutics Inc. emerge as key contributors to market growth - Technavio
Published: 2023-05-17 (Crawled : 21:00) - prnewswire.com
RBGPF | $51.61 6.46% 4.7K
|
Consumer Non-Durables
|
| O: -0.55%
H: 2.89%
C: -0.35%
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -4.32%
H: 1.69%
C: 1.69%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: -2.3%
RBGLY | $10.35 -2.05% 990K
|
Manufacturing
|
| O: -0.18%
H: 0.24%
C: -0.08%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.49%
H: 0.42%
C: -0.37%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.55%
H: 0.11%
C: -1.04%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.08%
H: 0.1%
C: -0.24%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.28%
H: 0.31%
C: -0.93%
drug therapeutics growth market
LaNova Medicines Announces Global Exclusive License Agreement with AstraZeneca for LM-305, a Novel GPRC5D-Targeting Antibody Drug Conjugate
Published: 2023-05-12 (Crawled : 21:00) - biospace.com/
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.29%
H: 0.81%
C: -0.29%
lm-305 drug antibody license global agreement
Global Nasal Vaccines Markets and Pipeline Analysis Research Report 2022: A Major Game Changer in Blocking the Transmission of Diseases Such as COVID-19
Published: 2023-01-10 (Crawled : 21:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.28%
H: 0.0%
C: -0.82%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.33%
H: 0.13%
C: -1.28%
covid-19 research global report
Acute Ischemic Stroke Therapeutics Market: Growth Opportunities led by Athersys Inc. and Bayer AG - Technavio
Published: 2022-11-28 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.36%
H: 0.16%
C: 0.16%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.93%
H: 0.0%
C: 0.0%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: 0.35%
H: 0.99%
C: 0.1%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.18%
H: 0.14%
C: -0.52%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.27%
H: 0.99%
C: 0.11%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.21%
H: 0.16%
C: -0.41%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: -0.49%
stroke therapeutics growth
Peptide Therapeutics Global Market to Reach $52.19 Billion by 2026 at a CAGR of 8.9%
Published: 2022-11-02 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.7%
H: 0.29%
C: 0.29%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -2.33%
H: 3.2%
C: 3.2%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -1.51%
H: 0.95%
C: 0.45%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.26%
H: 1.87%
C: 1.59%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.85%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -1.31%
H: 1.98%
C: 1.71%
global therapeutics market
Global Central Nervous System Therapeutics Market to Grow at Healthy CAGR Due to Rising Disorder Prevalence & Technical Advancements
Published: 2022-09-19 (Crawled : 21:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -6.97%
H: 7.7%
C: -0.76%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.34%
H: 6.64%
C: -0.06%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.96%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.82%
H: 0.07%
C: -0.61%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.71%
H: 0.2%
C: -0.23%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: -0.69%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.18%
H: 0.0%
C: 0.0%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.71%
H: 0.08%
C: -1.72%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -1.16%
H: 0.56%
C: 0.14%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.98%
H: 0.65%
C: -0.35%
global system therapeutics market
Sickle Cell Disease Treatment Global Market to Reach $4 Billion by 2027
Published: 2022-09-16 (Crawled : 21:00) - prnewswire.com
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
| Email alert
Add to watchlist
treatment global disease market
Global $30+ Billion Cervical Cancer Drugs Market, 2022-2026 - Pipeline Drugs ISA101, AGEN2034, and Z-100 Anticipated to Drive the Market
Published: 2022-08-16 (Crawled : 21:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.7%
H: 0.55%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.1%
H: 3.42%
C: 2.2%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.3%
H: 1.45%
C: 0.88%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.46%
H: 0.46%
C: -0.94%
isa101 global cancer market
Global Opioids Market to 2027 - Size, Share & Industry Trends Analysis Report
Published: 2022-06-24 (Crawled : 21:00) - prnewswire.com
ENDP | $0.2926 -9.6%
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
| Email alert
Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
| Email alert
Add to watchlist
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
trends report market
ChemoCentryx Announces Changes to its Board of Directors
Published: 2022-05-31 (Crawled : 21:00) - ir.chemocentryx.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.31%
H: 0.0%
C: -3.37%
SHC | $10.95 0.46% 0.46% 950K
|
Commercial Services
|
| O: 0.09%
H: 1.37%
C: 0.66%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.04%
H: 2.19%
C: 1.64%
VXRT | News | $0.7652 -9.15% -10.08% 1.9M
|
Health Technology
|
| O: -0.27%
H: 2.96%
C: -2.15%
CCXI | $51.99 -0.04%
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -4.87%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -2.24%
H: 1.32%
C: 0.9%
Insights on the Precision Medicine Global Market to 2027 - by Product, Technology, Application, End-user and Region
Published: 2022-05-17 (Crawled : 21:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -2.66%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.87%
H: 0.0%
C: 0.0%
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: -0.72%
H: 0.59%
C: -0.22%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -2.2%
H: 0.85%
C: -2.05%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.31%
H: 0.53%
C: -0.19%
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
|
| O: 1.09%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 1.57%
H: 0.0%
C: 0.0%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -2.2%
H: 0.85%
C: -2.05%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -1.92%
H: 0.5%
C: -1.4%
market
AstraZeneca progresses Ambition Zero Carbon programme with Honeywell partnership to develop next-generation respiratory inhalers
Published: 2022-02-22 (Crawled : 21:00) - biospace.com/
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 3.24%
H: 0.18%
C: -1.6%
partnership program respiratory one
TROPION-Breast01 Phase 3 Trial of Datopotamab Deruxtecan Initiated in Patients with Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Published: 2021-11-18 (Crawled : 21:00) - biospace.com/
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -1.46%
H: 0.33%
C: -0.32%
positive cancer phase 3 breast cancer trial initiated hormone her2+ her2- her2 metastatic breast cancer
Worldwide Active Pharmaceutical Ingredient Industry to 2030 - Growing Importance of Generics is Driving the Market
Published: 2021-11-12 (Crawled : 21:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
growing
Global Autoimmune Disease Diagnostics Market Report 2021: Market is Expected to Reach $7.84 Bn by 2026 - Rise in Online Diagnostic Centres and Laboratory Automation
Published: 2021-08-25 (Crawled : 21:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.35%
H: 0.74%
C: 0.5%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 0.63%
H: 0.67%
C: 0.22%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.33%
H: 0.26%
C: 0.03%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: 0.16%
H: 0.31%
C: -0.52%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.04%
H: 1.27%
C: 0.63%
TRIB | $1.81 -3.72% -3.87% 5.7K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -4.74%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: 0.63%
H: 0.67%
C: 0.22%
GRFS | News | $6.29 -3.82% -3.97% 1.2M
|
Health Technology
|
| O: -0.76%
H: 0.14%
C: -1.87%
XGN | $1.42 -0.62% -0.63% 6.6K
|
Health Services
|
| O: 0.0%
H: 1.71%
C: -0.82%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.48%
H: 0.34%
C: -0.17%
disease diagnostics diagnostic
Sierra Oncology Signs Exclusive Global In-Licensing Agreement with AstraZeneca for Novel BET Inhibitor to Expand Myelofibrosis Pipeline
Published: 2021-08-05 (Crawled : 21:00) - biospace.com/
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 0.0%
H: 5.03%
C: 3.82%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.48%
H: 0.46%
C: 0.43%
fibrosis license
Insights on the Diabetes Injection Pens Global Market to 2027 - AstraZeneca, Biocon and Novo Nordisk Among Others
Published: 2021-05-11 (Crawled : 21:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.73%
H: 1.3%
C: 1.11%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.0%
H: 0.46%
C: -0.8%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -0.48%
H: 1.47%
C: 0.67%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.15%
H: 0.55%
C: -0.4%
diabetes injection
AVEO Oncology Reports First Quarter 2021 Financial Results and Provides Business Update
Published: 2021-05-10 (Crawled : 21:00) - investor.aveooncology.com
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: -3.98%
H: 14.59%
C: 9.78%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -1.93%
H: 1.6%
C: 1.44%
financial results results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.